40 Participants Needed

Surgical Methods for Uterine Septum

MM
SL
Overseen BySarah L Rodriguez, MD
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: Northwestern University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot be on blood thinners to participate.

What data supports the effectiveness of this treatment for uterine septum?

Research shows that hysteroscopic septoplasty, which involves removing a uterine septum, is a safe and effective treatment for improving pregnancy outcomes in women with a septate uterus. It is associated with better reproductive outcomes, such as reduced recurrent miscarriages and improved live birth rates, compared to traditional surgical methods.12345

Is hysteroscopic surgery for uterine septum generally safe?

Hysteroscopic surgery for uterine septum, such as metroplasty, is generally considered safe with low risk of complications when performed by trained professionals. However, there is a rare risk of uterine rupture during a future pregnancy after the procedure.13567

How does hysteroscopic septoplasty differ from other treatments for uterine septum?

Hysteroscopic septoplasty is unique because it is a minimally invasive procedure that uses a hysteroscope (a thin, lighted tube) to remove the uterine septum, either with scissors or bipolar electrosurgery, avoiding the need for more invasive abdominal surgery. This approach is associated with lower risk and quicker recovery, making it the preferred treatment for uterine septa.15789

What is the purpose of this trial?

The objective of this study is to determine if the use of scissors without electrosurgery is superior to bipolar electrosurgery for resection of uterine septum. The investigators will be comparing procedure-level variables such as operative time, complications, and need for additional procedures.

Eligibility Criteria

This trial is for individuals with a uterine septum, which is an extra piece of tissue in the uterus. Participants should not have any other health issues that could complicate surgery. The study aims to find out if removing this tissue without using electricity (electrosurgery) is better than the current method.

Inclusion Criteria

I am between 20 and 44 years old.
My MRI or 3D imaging shows a septum thicker than 1.0 cm.

Exclusion Criteria

I am not taking any blood thinners.
I do not have a laparoscopy planned.
I have a diagnosed condition affecting my fallopian tubes.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo hysteroscopic septoplasty using either bipolar electrosurgery or scissors without electrosurgery

During the surgery

Follow-up

Participants have a routine follow-up visit to assess septum resolution and potential need for additional procedures

4 weeks
1 visit (in-person)

Post-operative Monitoring

Participants' recovery and satisfaction are assessed with follow-up phone calls

1 week

Treatment Details

Interventions

  • Hysteroscopic septoplasty utilizing bipolar electrosurgery
  • Removal of uterine septum with hysteroscopic scissors without electrosurgery
Trial Overview The study compares two surgical methods for treating a uterine septum: one uses scissors without electrosurgery and the other uses bipolar electrosurgery. It will look at how long the surgery takes, what complications might occur, and whether additional procedures are needed afterwards.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Study Intervention B (study group)Experimental Treatment1 Intervention
Hysteroscopic septoplasty utilizing scissors without electrosurgery followed by hysteroscopic morcellation of residual tissue
Group II: Study Intervention A (control group)Active Control1 Intervention
Hysteroscopic septoplasty utilizing bipolar electrosurgery

Hysteroscopic septoplasty utilizing bipolar electrosurgery is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Hysteroscopic septoplasty for:
  • Uterine septum
  • Infertility
  • Abnormal uterine bleeding
🇺🇸
Approved in United States as Hysteroscopic septoplasty for:
  • Uterine septum
  • Infertility
  • Abnormal uterine bleeding
  • Recurrent miscarriage
🇨🇦
Approved in Canada as Hysteroscopic septoplasty for:
  • Uterine septum
  • Infertility
  • Abnormal uterine bleeding

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials
1,674
Recruited
989,000+

Findings from Research

Hysteroscopic metroplasty, a minimally invasive surgical technique, was successfully performed on 11 patients with septate uterus, showing good surgical outcomes without any intra- or postoperative complications.
The initial results suggest that if pregnancy outcomes improve as expected, hysteroscopic metroplasty could replace traditional abdominal surgery as the preferred treatment for uterine septa, potentially reducing recovery time and risks associated with more invasive procedures.
Hysteroscopic treatment of uterine septa.Perino, A., Cittadini, E., Hamou, J., et al.[2004]
Hysteroscopic septoplasty is an effective procedure for treating a septate uterus, particularly beneficial for women with recurrent pregnancy losses, potentially improving live birth rates.
While enlarging hysteroscopic metroplasty shows promise in enhancing obstetrical outcomes for certain uterine malformations, evidence is insufficient to recommend it as a first-line treatment except in specific cases, such as older women or prior to assisted reproductive techniques.
[Do hysteroscopic metroplasties really improve really reproductive outcome?].Garbin, O., Ziane, A., Castaigne, V., et al.[2013]
Hysteroscopic metroplasty, a procedure to improve pregnancy outcomes for women with a uterine septum, carries a risk of uterine rupture during subsequent pregnancies, as demonstrated by a case of a patient experiencing this complication at 28 weeks.
Despite being rare, the occurrence of uterine rupture after this procedure highlights the need for patients to be informed about this potential risk in future pregnancies, although strategies to prevent such complications remain unclear.
Spontaneous uterine rupture with amniotic sac protrusion at 28 weeks subsequent to previous hysteroscopic metroplasty.Conturso, R., Redaelli, L., Pasini, A., et al.[2019]

References

Hysteroscopic treatment of uterine septa. [2004]
[Do hysteroscopic metroplasties really improve really reproductive outcome?]. [2013]
Spontaneous uterine rupture with amniotic sac protrusion at 28 weeks subsequent to previous hysteroscopic metroplasty. [2019]
Hysteroscopic metroplasty of the complete uterine septum, duplicate cervix, and vaginal septum. [2006]
Reproductive outcome after operative hysteroscopy for uterine septum: scissors or diathermy? [2020]
Reproductive outcomes and risk factors of women with septate uterus after hysteroscopic metroplasty. [2023]
[Septate uterus: role of hysteroscopic metroplasty]. [2007]
Metroplasty for the complete septate uterus: does cervical sparing matter? [2019]
Uterine rupture after hysteroscopic metroplasty and labor induction. A case report. [2016]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security